157 related articles for article (PubMed ID: 36419077)
1. Lymphadenectomy in ovarian cancers: a meta-analysis of hazard ratios from randomized clinical trials.
Purwar R; Ranjan R; Soni K; Pandey M; Upadhyay SK; Pai E; Kumar T
World J Surg Oncol; 2022 Nov; 20(1):367. PubMed ID: 36419077
[TBL] [Abstract][Full Text] [Related]
2. Lymphadenectomy for primary ovarian cancer: a systematic review and meta-analysis.
Chiyoda T; Sakurai M; Satoh T; Nagase S; Mikami M; Katabuchi H; Aoki D
J Gynecol Oncol; 2020 Sep; 31(5):e67. PubMed ID: 32808497
[TBL] [Abstract][Full Text] [Related]
3. The role of systematic pelvic and para-aortic lymphadenectomy in the management of patients with advanced epithelial ovarian, tubal, and peritoneal cancer: A systematic review and meta-analysis.
Tzanis AA; Antoniou SA; Zacharoulis D; Ntafopoulos K; Tsouvali H; Daponte A
Eur J Obstet Gynecol Reprod Biol; 2023 Jun; 285():198-203. PubMed ID: 37149928
[TBL] [Abstract][Full Text] [Related]
4. The value of systematic lymphadenectomy during debulking surgery in the treatment of ovarian cancer: a meta-analysis of randomized controlled trials.
Lin Q; Liu W; Xu S; Li J; Tong J
J Ovarian Res; 2020 May; 13(1):56. PubMed ID: 32384898
[TBL] [Abstract][Full Text] [Related]
5. The role systematic lymphadenectomy plays in determining the survival outcome for advanced ovarian cancer patients: a meta-analysis.
Xu D; Xue J; Rozan R; Li L
Ann Palliat Med; 2020 May; 9(3):912-920. PubMed ID: 32389005
[TBL] [Abstract][Full Text] [Related]
6. Systematic lymphadenectomy for survival in epithelial ovarian cancer: a meta-analysis.
Kim HS; Ju W; Jee BC; Kim YB; Park NH; Song YS; Kim SC; Kang SB; Kim JW
Int J Gynecol Cancer; 2010 May; 20(4):520-8. PubMed ID: 20686371
[TBL] [Abstract][Full Text] [Related]
7. Survival benefits of pelvic lymphadenectomy versus pelvic and para-aortic lymphadenectomy in patients with endometrial cancer: A meta-analysis.
Guo W; Cai J; Li M; Wang H; Shen Y
Medicine (Baltimore); 2018 Jan; 97(1):e9520. PubMed ID: 29505525
[TBL] [Abstract][Full Text] [Related]
8. Lymphadenectomy extent and survival of patients with gastric carcinoma: a systematic review and meta-analysis of time-to-event data from randomized trials.
Mocellin S; Nitti D
Cancer Treat Rev; 2015 May; 41(5):448-54. PubMed ID: 25814393
[TBL] [Abstract][Full Text] [Related]
9. Extent of lymph node dissection for adenocarcinoma of the stomach.
Mocellin S; McCulloch P; Kazi H; Gama-Rodrigues JJ; Yuan Y; Nitti D
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD001964. PubMed ID: 26267122
[TBL] [Abstract][Full Text] [Related]
10. Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: a randomized clinical trial.
Panici PB; Maggioni A; Hacker N; Landoni F; Ackermann S; Campagnutta E; Tamussino K; Winter R; Pellegrino A; Greggi S; Angioli R; Manci N; Scambia G; Dell'Anna T; Fossati R; Floriani I; Rossi RS; Grassi R; Favalli G; Raspagliesi F; Giannarelli D; Martella L; Mangioni C
J Natl Cancer Inst; 2005 Apr; 97(8):560-6. PubMed ID: 15840878
[TBL] [Abstract][Full Text] [Related]
11. The use of bevacizumab in the modern era of targeted therapy for ovarian cancer: A systematic review and meta-analysis.
Liu S; Kasherman L; Fazelzad R; Wang L; Bouchard-Fortier G; Lheureux S; Krzyzanowska MK
Gynecol Oncol; 2021 May; 161(2):601-612. PubMed ID: 33546867
[TBL] [Abstract][Full Text] [Related]
12. Combined pelvic and para-aortic is superior to only pelvic lymphadenectomy in intermediate and high-risk endometrial cancer: a systematic review and meta-analysis.
Petousis S; Christidis P; Margioula-Siarkou C; Papanikolaou A; Dinas K; Mavromatidis G; Guyon F; Rodolakis A; Vergote I; Kalogiannidis I
Arch Gynecol Obstet; 2020 Jul; 302(1):249-263. PubMed ID: 32468162
[TBL] [Abstract][Full Text] [Related]
13. The efficacy and toxicity of angiogenesis inhibitors for ovarian cancer: a meta-analysis of randomized controlled trials.
Guo C; Yan C; Qu L; Du R; Lin J
Arch Gynecol Obstet; 2021 Feb; 303(2):285-311. PubMed ID: 33222040
[TBL] [Abstract][Full Text] [Related]
14. Does complete-staging lymphadenectomy improve survival outcomes in stage I endometrioid epithelial ovarian carcinoma? A multi-institutional retrospective study with propensity score-weighted analysis.
Yoshihara M; Tamauchi S; Iyoshi S; Kitami K; Uno K; Tano S; Matsui S; Kajiyama H
Jpn J Clin Oncol; 2021 Mar; 51(3):387-392. PubMed ID: 33253382
[TBL] [Abstract][Full Text] [Related]
15. Prognostic impact of pelvic and para-aortic lymphadenectomy on clinically-apparent stage I primary mucinous epithelial ovarian carcinoma: a multi-institutional study with propensity score-weighted analysis.
Yoshihara M; Kajiyama H; Tamauchi S; Iyoshi S; Yokoi A; Suzuki S; Kawai M; Nagasaka T; Takahashi K; Matsui S; Kikkawa F
Jpn J Clin Oncol; 2020 Feb; 50(2):145-151. PubMed ID: 31688935
[TBL] [Abstract][Full Text] [Related]
16. Influence of lymphadenectomy on survival and recurrence in patients with early-stage epithelial ovarian cancer: a meta-analysis.
Yang C; Zhang T; Gong A; Shi C
BMC Womens Health; 2023 Sep; 23(1):474. PubMed ID: 37667358
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of systematic lymphadenectomy as part of primary debulking surgery in patients with advanced ovarian cancer.
Chang SJ; Bristow RE; Ryu HS
Gynecol Oncol; 2012 Sep; 126(3):381-6. PubMed ID: 22609747
[TBL] [Abstract][Full Text] [Related]
18. Potential role of lymphadenectomy in advanced ovarian cancer: a combined exploratory analysis of three prospectively randomized phase III multicenter trials.
du Bois A; Reuss A; Harter P; Pujade-Lauraine E; Ray-Coquard I; Pfisterer J; ;
J Clin Oncol; 2010 Apr; 28(10):1733-9. PubMed ID: 20194855
[TBL] [Abstract][Full Text] [Related]
19. [Are there still indications of lymph node dissection in epithelial ovarian cancers after the LION trial?].
Azaïs H; Canlorbe G; Nikpayam M; Gonthier C; Belghiti J; Uzan C
Bull Cancer; 2020 Jun; 107(6):707-714. PubMed ID: 31587803
[TBL] [Abstract][Full Text] [Related]
20. Luteinising hormone releasing hormone (LHRH) agonists for the treatment of relapsed epithelial ovarian cancer.
Wuntakal R; Seshadri S; Montes A; Lane G
Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD011322. PubMed ID: 27356090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
